Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice

Fibroblast growth factor (FGF) 21 is an endocrine factor that normalizes glucose homeostasis and reduces insulin resistance in diabetes. Although the pancreas is an FGF21 target organ, its role in pancreatic islets remains obscure. This study aimed to elucidate the physiological role of FGF21 in pan...

Descripción completa

Detalles Bibliográficos
Autores principales: So, W Y, Cheng, Q, Xu, A, Lam, K S L, Leung, P S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385948/
https://www.ncbi.nlm.nih.gov/pubmed/25811804
http://dx.doi.org/10.1038/cddis.2015.80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385948/
https://www.ncbi.nlm.nih.gov/pubmed/25811804
http://dx.doi.org/10.1038/cddis.2015.80

Ejemplares similares